SMAIO: Success of a New Educational Program in the United States Designed to Promote SMAIO Technology in the World's Leading Spine Market
November 21 2023 - 12:00PM
Business Wire
Regulatory News:
SMAIO (Software, Machines and
Adaptative Implants in Orthopaedics – Euronext
Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA), a French player
specialized in complex spine surgery with a global offer comprising
software, adaptative implants and related services, today announces
the successful completion of its 2nd U.S training and reflection
program on sagittal balance, held in San Diego (California) in
mid-November 2023.
As a follow-up to the first four “Sagittal Alignment Academy”
training programs for its European (Copenhagen, Madrid and Brussels
in October 2022 and April 2023) and North American (Dallas in
November 2022) customers, SMAIO continues to intensify the
dissemination of its holistic approach to spine surgery in the
United States, the world's largest spine surgery market, with the
first “Sagittal Alignment Think Tank”.
Emphasizing its expertise in restoring patients' spinal
alignment and having succeeded in convincing a college of 8 of the
most recognized faculties in both the United States and Europe,
SMAIO has launched its Sagittal Balance Academy in a "Think Tank"
format. This new initiative leaves plenty of room for discussion
between participants selected from among the best spinal deformity
surgeons in the United States. A total of 24 U.S surgeons met for a
day in San Diego, where they were able to use KEOPS Balance
Analyzer 3D software to analyze real cases requiring vertebral
realignment, and to take part in several workshops on realistic
simulators using Kheiron Spinal Fixation System osteosynthesis
equipment, two flagship products in the SMAIO portfolio.
SMAIO's objective is to develop a consensus with U.S. surgeons
on a patient-specific method of spinal realignment, based on the
extensive data in SMAIO's KEOPS database and the artificial
intelligence technologies that leverage it. The Think Tank's
hands-on workshops also gave them the opportunity to understand how
the i-kontrol platform enables them to precisely plan and execute
spinal realignment surgeries in their daily practice.
To date, five U.S. surgeons are actively involved in the
preliminary launch phase of i-kontrol in the United States, which
is due to be completed at the end of 2023, giving way to the "full
release" phase, which aims to triple the number of users of SMAIO
solutions in the United States by 2025.
Philippe ROUSSOULY, Chairman and CEO of SMAIO, comments:
“SMAIO's commercial strategy is based on significant expansion in
the United States. These training courses are therefore of
instrumental in promoting our technological and scientific offering
to a wide range of surgeons in this strategic country, where
selling prices are higher than in other geographies. Thanks to the
very positive feedback, we are enthusiastic about continuing to
train and support surgeons, helping them to carry out personalized
interventions to promote optimal and lasting balance in
patients.”
Prof. Munish Gupta (MD), Spine surgeon and Professor of
orthopaedic surgery at the Washington University School of Medicine
in St. Louis, adds: “The sagittal alignment course was a truly
amazing educational opportunity to discuss the most cutting edge
thinking of the sagittal plane in adult spine deformity. I was very
impressed with the software and technology to produce
patient-specific rods by SMAIO. This technology can help a lot of
spine surgeons around the world.”
About SMAIO
A precursor in the use of clinical data and imaging of the
spine, SMAIO designs global solutions for spine surgery
specialists. The Company has recognized expertise thanks to KEOPS,
its Big Data management software that has become a global reference
with more than 100,000 patient cases documented.
SMAIO offers spine surgeons a comprehensive platform, I-Kontrol,
incorporating planning, implants and related services, enabling
them to treat spinal pathologies in a safe, effective and lasting
way.
SMAIO is positioned at the forefront of innovation with the
ambition of providing surgeons with the first active robotic
solution enabling a high level of performance and repeatability to
be achieved.
Based in Lyon, France, SMAIO benefits from the skill and
expertise of more than 30 highly specialized staff.
For further information, please visit our website:
www.smaio.com
Listing market: Euronext Growth Paris ISIN:
FR0014005I80 Ticker: ALSMA
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231121453860/en/
SMAIO Philippe Roussouly Chief Executive Officer Renaut
Fritsch Chief Financial Officer investors@smaio.com
NewCap Dusan Oresansky/Quentin Massé Investor Relations
smaio@newcap.eu Tel.: +33 (0)1 44 71 94 92
NewCap Arthur Rouillé Media Relations smaio@newcap.eu
Tel.: +33 (0)1 44 71 00 15
SMAIO (EU:ALSMA)
Historical Stock Chart
From Nov 2024 to Dec 2024
SMAIO (EU:ALSMA)
Historical Stock Chart
From Dec 2023 to Dec 2024